Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations
Clinical trial NCT05277701 · UNKNOWN
Trial details
- NCT number
- NCT05277701
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2024-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.